Royalty Pharma Sub-Manager, LLC

Position in BCAX — Bicara Therapeutics Inc.

CIK 2081668 New York, NY

Position in BCAX

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$47,500,303

+$26,241,489 QoQ

Shares Held

2,388,150

+89.1% QoQ

Ownership

3.63%

of shares outstanding

% of Portfolio

27.37%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Royalty Pharma Sub-Manager, LLC holds $136,960,788 across 3 Biotechnology names. BCAX ranks #2 (34.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CYTK	Cytokinetics Inc	980,392	$64,617,636
2	BCAX	Bicara Therapeutics Inc. This page	2,388,150	$47,500,303
3	BHVN	Biohaven Ltd.	2,936,507	$24,842,849

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$47,500,303	2,388,150	+89.1%	Shares	Defined	2026-05-14
2025-12-31	$21,258,814	1,263,150	—	Shares	Defined	2026-04-01
No filing history on record for this holder in this stock.